Effectiveness of recombinant activated factor VII (rFVII a) for controlling intractable postpartum bleeding: report of two cases and literature review
Jirapinyo, M.; Manonai, J.; Herabutya, Y.; Chuncharunee, S.
Journal of the Medical Association of Thailand 90(5): 977-981
2007
ISSN/ISBN: 0125-2208 PMID: 17596055 Document Number: 2842
Background. Recombinant activated factor VII is used for the treatment in patients with inherited or acquired hemophilia with inhibitors and congenital factor VII deficiencies.Objective: Using recombinant activated factor VII in primary postpartum hemorrhage.Material and Method: Two cases of women who had postpartum hemorrhage and were treated with recombinant activated factor VII after all conventional treatment failed.Results: The intractable hemorrhage stopped after treatment with recombinant activated factor VII.Conclusion: The present report showed that massive postpartum hemorrhage that failed to all procedures was controlled successfully by recombinant activated factor VII.
Document emailed within 1 workday